Does Kaiser Permanente cover Zepbound for weight loss?

Covered, prior authorization. Non-formulary, so it needs a clinical review. Adults 18 and over, weight and BMI documented in the last 30 days, no personal or family history of medullary thyroid carcinoma or MEN 2. Approval runs 12 months.

Insurer and benefit manager

Does Kaiser Permanente cover GLP-1s for weight loss?

Kaiser puts it above every clinical test: Zepbound is covered for weight loss "ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price." The first criterion in the list is having the benefit at all.

By John Weeks Checked against the primary source August 25, 2026

Your employer decides, not Kaiser Permanente. On most commercial plans, whether weight-loss medication is covered at all is chosen by whoever buys the plan. The criteria below apply only once that choice has been made, so the first document to read is your own plan's benefit summary.

What Kaiser Permanente covers for weight loss, and the criteria that apply.
Medication	Position	What it asks for
Zepbound	Prior authorization	Non-formulary, so it needs a clinical review. Adults 18 and over, weight and BMI documented in the last 30 days, no personal or family history of medullary thyroid carcinoma or MEN 2. Approval runs 12 months.
Wegovy	not checked	Kaiser publishes criteria per drug and per region. The Wegovy document was not read, and a Zepbound policy does not answer for Wegovy.

Zepbound Prior authorization

Non-formulary, so it needs a clinical review. Adults 18 and over, weight and BMI documented in the last 30 days, no personal or family history of medullary thyroid carcinoma or MEN 2. Approval runs 12 months.
Wegovy not checked

Kaiser publishes criteria per drug and per region. The Wegovy document was not read, and a Zepbound policy does not answer for Wegovy.

Worth knowing

Kaiser is integrated, so the health plan and the pharmacy are one organization and the criteria are its own rather than a pharmacy benefit manager’s. It runs eight regions with separate committees. What is recorded here is the Northwest region, and it does not answer for the others.

Asking about one medicine instead

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

1 cited records

1
Kaiser Permanente Northwest Region Criteria for Coverage: tirzepatide (Zepbound)
Kaiser Permanente Primary text read and checked Checked August 25, 2026